According to the NCI website, necitumumab is a fully human IgG1 monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity.

Link to Drug Information Portal

Link to National Cancer Institute

Link zu Wiki

Monoclonal Antibodies